Citation： 文天夫. ALPPS在肝细胞癌治疗中的地位. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2016, 23(1): 1-4. doi: 10.7507/1007-9424.20160001 Copy
| 1. | Alfredo Guglielmi, Andrea Ruzzenente, Simone Conci, et al. Hepa-tocellular carcinoma:surgical perspectives beyond the barcelona clinic liver cancer recommendations. World J Gastroenterol, 2014, 20(24):7525-7533. |
| 2. | Jordi Bruix, Gregory J Gores, Vincenzo Mazzaferro. Hepatocellular carcinoma:clinical frontiers and perspectives. Gut, 2014, 63(5):844-855. |
| 3. | de Santibanes E, Clavien PA. Playing Play-Doh to preventposto-perative liver failure:the"ALPPS"approach. Ann Surg, 2012, 255(3):415-417. |
| 4. | Wang H, Yang J, Yang J, et al. Development and validation of a prediction score for complications after hepatectomy in hepatitis B-related hepatocellular carcinoma patients. PLoS One, 2014, 9(8):e105114. |
| 5. | Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embo-lization to increase safety of major hepatectomy for hilar bile duct carcinoma:a preliminary report. Surgery, 1990, 107(5):521-527. |
| 6. | Pamecha V, Levene A, Grillo F, et al. Effect of portal vein embolisa-tion on the growth rate of colorectal liver metastases. Br J Cancer, 2009, 100(4):617-622. |
| 7. | Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy:a planned strategy to treat irresectable liver tumors. Ann Surg, 2000, 232(6):777-785. |
| 8. | Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg, 2004, 240(6):1037-1049, 1051. |
| 9. | Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med, 2007, 356(15):1545-1559. |
| 10. | Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portalvein ligation combined with in situ splitting induces rapid leftlateral liver lobe hypertrophy enabling 2-staged extended righthepatic resection in small-for-size settings. Ann Surg, 2012, 255(3):405-414. |
| 11. | de Santibanes E, Alvarez FA, Ardiles V. How to avoid postoperative liver failure:a novel method. World J Surg, 2012, 36(2):125-128. |
| 12. | European Association for the Study of the Liver; European Organisa-tion for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma. J Hepatol, 2012, 56(4):908-943. |
| 13. | Tang ZY, Yu YQ, Lin ZY, et al. Small hepatocellular carcinoma:analysis of 30 cases. Chin Med J (Engl), 1979, 92(7):455-462. |
| 14. | Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996, 334(11):693-699. |
| 15. | Yau T, Tang VY, Yao TJ, et al. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology, 2014, 146(7):1691-1700. |
| 16. | 高杰, 朱继业.卫生部《原发性肝癌诊疗规范(2011年版)》解读.中华普通外科杂志, 2012, 7(8):693-695. |
| 17. | Lei JY, Yan LN, Wang WT, et al. Barcelona clinic liver cancer stage B hepatocellular carcinoma:transarterial chemoembolization or hepatic resection? Medicine (Baltimore), 2014, 93(26):e180. |
| 18. | Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria:a RCT. J Hepatol, 2014, 61(1):82-88. |
| 19. | Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers:is it adherent to the EASL/AASLD recommendations? an observational study of the HCC East-West study group.Ann Surg, 2013, 257(5):929-937. |
| 20. | Roayaie S, Jibara G, Tabrizian P, et al. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology, 2015, 62(2):440-451. |
| 21. | 周俭, 王征, 孙健, 等.联合肝脏离断和门静脉结扎的二步肝切除术.中华消化外科杂志, 2013, 12(7):485-489. |
| 22. | Chan AC, Poon RT, Lo CM. Modified anterior approach for the ALPPS procedure:how we do it. World J Surg, 2015, 39(11):2831-2835. |
| 23. | 彭驰涵, 李川, 文天夫, 等.原发性肝癌行ALPPS的适应征禁忌证初探(附15例报道).中国普外基础与临床杂志, 2015, 22(10):1183-1186. |
| 24. | D'Haese JG, Neumann J, Weniger M, et al. Should ALPPS be used for liver rResection in intermediate-sStage HCC? Ann Surg Oncol, 2015 Dec 8.[Epub ahead of print]. |
| 25. | van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection:a systematic review. Cardiovasc Intervent Radiol, 2013, 36(1):25-34. |
| 26. | Heinzow HS, Brockmann JG, Köhler M, et al. Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria-is it time for a more individual approach? Ann Transplant, 2013, 18:515-524. |
| 27. | Xu X, Lu D, Ling Q, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut, 2015 Mar 24.[Epub ahead of print]. |
| 28. | Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conven-tional approach right hepatic resection for large hepatocellular carcinoma:a prospective randomized controlled study. Ann Surg, 2006, 244(2):194-203. |
| 29. | 张宇, 陈云飞, 路涛, 等.全腹腔镜前入路经肝后隧道绕肝带结扎并门静脉结扎的分期肝切除术治疗肝硬变肝癌.中国普外基础与临床杂志, 2015, 22(1):70-75. |
| 30. | Robles R, Parrilla P, López-Conesa A, et al. Tourniquet modifica-tion of the associating liver partitionand portal ligation for staged hepatectomy procedure. Br J Surg, 2014, 101(9):1129-1134. |
| 31. | Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg, 2015, 261(4):e90-e92. |
| 32. | Machado MA, Makdissi FF, Suran RC. Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg, 2012, 256(3):e13; author reply e16-e19. |
- 1. Alfredo Guglielmi, Andrea Ruzzenente, Simone Conci, et al. Hepa-tocellular carcinoma:surgical perspectives beyond the barcelona clinic liver cancer recommendations. World J Gastroenterol, 2014, 20(24):7525-7533.
- 2. Jordi Bruix, Gregory J Gores, Vincenzo Mazzaferro. Hepatocellular carcinoma:clinical frontiers and perspectives. Gut, 2014, 63(5):844-855.
- 3. de Santibanes E, Clavien PA. Playing Play-Doh to preventposto-perative liver failure:the"ALPPS"approach. Ann Surg, 2012, 255(3):415-417.
- 4. Wang H, Yang J, Yang J, et al. Development and validation of a prediction score for complications after hepatectomy in hepatitis B-related hepatocellular carcinoma patients. PLoS One, 2014, 9(8):e105114.
- 5. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embo-lization to increase safety of major hepatectomy for hilar bile duct carcinoma:a preliminary report. Surgery, 1990, 107(5):521-527.
- 6. Pamecha V, Levene A, Grillo F, et al. Effect of portal vein embolisa-tion on the growth rate of colorectal liver metastases. Br J Cancer, 2009, 100(4):617-622.
- 7. Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy:a planned strategy to treat irresectable liver tumors. Ann Surg, 2000, 232(6):777-785.
- 8. Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg, 2004, 240(6):1037-1049, 1051.
- 9. Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med, 2007, 356(15):1545-1559.
- 10. Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portalvein ligation combined with in situ splitting induces rapid leftlateral liver lobe hypertrophy enabling 2-staged extended righthepatic resection in small-for-size settings. Ann Surg, 2012, 255(3):405-414.
- 11. de Santibanes E, Alvarez FA, Ardiles V. How to avoid postoperative liver failure:a novel method. World J Surg, 2012, 36(2):125-128.
- 12. European Association for the Study of the Liver; European Organisa-tion for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma. J Hepatol, 2012, 56(4):908-943.
- 13. Tang ZY, Yu YQ, Lin ZY, et al. Small hepatocellular carcinoma:analysis of 30 cases. Chin Med J (Engl), 1979, 92(7):455-462.
- 14. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996, 334(11):693-699.
- 15. Yau T, Tang VY, Yao TJ, et al. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology, 2014, 146(7):1691-1700.
- 16. 高杰, 朱继业.卫生部《原发性肝癌诊疗规范(2011年版)》解读.中华普通外科杂志, 2012, 7(8):693-695.
- 17. Lei JY, Yan LN, Wang WT, et al. Barcelona clinic liver cancer stage B hepatocellular carcinoma:transarterial chemoembolization or hepatic resection? Medicine (Baltimore), 2014, 93(26):e180.
- 18. Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria:a RCT. J Hepatol, 2014, 61(1):82-88.
- 19. Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers:is it adherent to the EASL/AASLD recommendations? an observational study of the HCC East-West study group.Ann Surg, 2013, 257(5):929-937.
- 20. Roayaie S, Jibara G, Tabrizian P, et al. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology, 2015, 62(2):440-451.
- 21. 周俭, 王征, 孙健, 等.联合肝脏离断和门静脉结扎的二步肝切除术.中华消化外科杂志, 2013, 12(7):485-489.
- 22. Chan AC, Poon RT, Lo CM. Modified anterior approach for the ALPPS procedure:how we do it. World J Surg, 2015, 39(11):2831-2835.
- 23. 彭驰涵, 李川, 文天夫, 等.原发性肝癌行ALPPS的适应征禁忌证初探(附15例报道).中国普外基础与临床杂志, 2015, 22(10):1183-1186.
- 24. D'Haese JG, Neumann J, Weniger M, et al. Should ALPPS be used for liver rResection in intermediate-sStage HCC? Ann Surg Oncol, 2015 Dec 8.[Epub ahead of print].
- 25. van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection:a systematic review. Cardiovasc Intervent Radiol, 2013, 36(1):25-34.
- 26. Heinzow HS, Brockmann JG, Köhler M, et al. Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria-is it time for a more individual approach? Ann Transplant, 2013, 18:515-524.
- 27. Xu X, Lu D, Ling Q, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut, 2015 Mar 24.[Epub ahead of print].
- 28. Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conven-tional approach right hepatic resection for large hepatocellular carcinoma:a prospective randomized controlled study. Ann Surg, 2006, 244(2):194-203.
- 29. 张宇, 陈云飞, 路涛, 等.全腹腔镜前入路经肝后隧道绕肝带结扎并门静脉结扎的分期肝切除术治疗肝硬变肝癌.中国普外基础与临床杂志, 2015, 22(1):70-75.
- 30. Robles R, Parrilla P, López-Conesa A, et al. Tourniquet modifica-tion of the associating liver partitionand portal ligation for staged hepatectomy procedure. Br J Surg, 2014, 101(9):1129-1134.
- 31. Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg, 2015, 261(4):e90-e92.
- 32. Machado MA, Makdissi FF, Suran RC. Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg, 2012, 256(3):e13; author reply e16-e19.